A modified analog of Aβ42 Fibrillogenesis Inhibitor I which can cross the blood-brain barrier. Exhibits greater stability against proteolytic degradation.
C-terminus is amidated.
Trusted by biotech leaders worldwide for over 40+ years of delivering high quality, fast and scalable synthetic biology solutions.